<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="29258">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02725827</url>
  </required_header>
  <id_info>
    <org_study_id>UW 16-158</org_study_id>
    <nct_id>NCT02725827</nct_id>
  </id_info>
  <brief_title>Hyaluronan-enriched Embryo Transfer Medium for Frozen-thawed Embryo Transfer</brief_title>
  <official_title>Randomized Controlled Trial Comparing Hyaluronan-enriched Embryo Transfer Medium Versus Control for Frozen-thawed Embryo Transfer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kwong Wah Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Hong Kong</source>
  <brief_summary>
    <textblock>
      This is a randomized-controlled trial evaluating the effect of the use of hyaluronan
      (HA)-enriched embryo transfer medium on the live birth rate in women undergoing
      frozen-thawed embryo transfer. For half of the women, hyaluonan-enriched medium will be used
      as embryo transfer medium. For the other half of women, control will be used.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Live-birth rate per embryo transfer procedure</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pregnancy rate</measure>
    <time_frame>4 weeks</time_frame>
    <description>positive urine pregnancy test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinical pregnancy rate</measure>
    <time_frame>4 weeks</time_frame>
    <description>presence of intrauterine gestational sac on ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>implantation rate</measure>
    <time_frame>8 weeks</time_frame>
    <description>number of gestational sacs per embryo transferred</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>on-going pregnancy rate</measure>
    <time_frame>8 weeks</time_frame>
    <description>viable pregnancy beyond gestation 8 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>obstetric complications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">550</enrollment>
  <condition>In Vitro Fertilization</condition>
  <condition>Subfertility</condition>
  <arm_group>
    <arm_group_label>HA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One the day of frozen-thawed embryo transfer, frozen embryos will be thawed and incubated for at least 10 minutes in embryo transfer medium. For women allocated to the HA group, EmbryoGlue (Vitrolife), a hyaluronan-enriched embryo transfer medium, will be used as embryo transfer medium. EmbryoGlue contains a higher concentration of hyaluronan than the control medium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For women allocated to the control group, the usual transfer medium used in the study centers will be used and will serve as control. The main difference between the two media is that EmbryoGlue contains a higher concentration of HA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EmbryoGlue (Vitrolife)</intervention_name>
    <description>A hyaluronan-enriched embryo transfer medium</description>
    <arm_group_label>HA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control medium</intervention_name>
    <description>The usual embryo transfer medium used in the study centres.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women panning to replacing early cleavage embryos or blastocysts after thawing.

        Exclusion Criteria:

          -  Frozen early cleavage embryos thawed and cultured to blastocysts prior to transfer as
             requested by the patient

          -  Preimplantation genetic diagnosis treatment

          -  Use of donor oocytes or donor embryos

          -  Endometrial thickness &lt;8mm on the day of the luteinizing hormone surge or after two
             weeks of estrogen in hormonal replacement cycles

          -  Hydrosalpinx shown on pelvic scanning and not surgically treated
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shuk Fei Sofie Yung, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shuk Fei Sofie Yung, MBBS</last_name>
    <phone>852-22554517</phone>
    <email>ssfyung@hku.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kwong Wah Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shui Fan Lai, MBBS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital, University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofie SF Yung, MBBS</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 16, 2017</lastchanged_date>
  <firstreceived_date>March 23, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Dr. YUNG Shuk Fei Sofie</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
